Suchergebnisse - "Fehn, Karen"

PubPharm (10)

1

Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome : Result of a Phase II Clinical Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Gonzalez-Lugo, J. | Kambhampati, S. | Yacoub, A. | +20

2

Autologous stem cell transplantation in an older adult population

enthalten in: Haematologica | 2022

von Fedorov, K. | Jain, T. | Pradhan, K. | +23

3

Treatment of severe COVID-19 with convalescent plasma in Bronx, NYC

enthalten in: JCI insight | 2021

von Yoon, H. | Bartash, R. | Gendlina, I. | +52

UpdateOf: medRxiv. 2020 Dec 04;:. - PMID 33300012

4

Patterns of leukocyte recovery predict infectious complications after CD19 CAR-T cell therapy in a real-world setting

enthalten in: Stem cell investigation | 2021

von Thakkar, A. | Cui, Z. | Peeke, S. | +45

5

Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer

enthalten in: Clinical breast cancer | 2018

von Anampa, J. | Chen, A. | Wright, J. | +5

6

A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

enthalten in: Breast cancer research and treatment | 2014

von Tu, Y. | Hershman, D. | Bhalla, K. | +13

7

Phase I-II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma

enthalten in: Breast cancer research and treatment | 2013

von Andreopoulou, E. | Vigoda, I. | Valero, V. | +11

8

Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2004

von Wadler, S. | Makower, D. | Clairmont, C. | +3

9

A pilot study of edrecolomab (Panorex, 17-1A antibody) and capecitabine in patients with advanced or metastatic adenocarcinoma

enthalten in: Cancer investigation | 2003

von Makower, D. | Sparano, J. | Wadler, S. | +5

10

Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies

enthalten in: American journal of clinical oncology | 2002

von Goel, S. | Jhawer, M. | Rajdev, L. | +9

1
[1]